drug
narsoplimab
Marketedupdated 3mo agoby $OMER OMEROS CORP
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(1)
Trials studying narsoplimab
- phase2Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
- —Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab
- phase3Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome
- phase2Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that